Benjamin P. Levy, MD; Zofia Piotrowska, MD; Lyudmila A. Bazhenova, MD; and Jonathan W. Riess, MD, MS, consider the rationale for using osimertinib versus whole-brain radiotherapy in EGFR-positive non–small cell lung cancer with brain metastases.

свернуть